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Abstract
Background: Glutaraldehyde-treated bioprosthetic heart valves are commonly used for replacement of diseased
heart valves. However, calcification and wear limit their durability, and the development of new and improved
bioprosthetic valve designs is needed and must be evaluated in a reliable animal model. We studied
glutaraldehyde-treated valves 6 months after implantation to evaluate bioprosthetic valve complications in the
mitral position in juvenile pigs.
Materials: The study material comprised eight, 5-month old, 60-kg pigs. All pigs received a size 27, glutaraldehyde-
treated, stented, Carpentier-Edwards S.A.V. mitral valve prosthesis. After six months, echocardiography was
performed, and the valves explanted for gross examination, high resolution X-ray, and histological evaluation.
Results: Five pigs survived the follow-up period. Preexplant echocardiography revealed a median peak and mean
velocity of 1.61 m/s (range: 1.17-2.00) and 1.20 (SD = ±0.25), respectively, and a median peak and mean pressure
difference of 10.42 mmHg (range: 5.83-16.55) and 6.51 mmHg (SD = ±2.57), respectively. Gross examination
showed minor thrombotic depositions at two commissures in two valves and at all three commissures in three
valves. High resolution X-ray imaging revealed different degrees of calcification in all explanted valves, primarily in
the commissural and belly areas. In all valves, histological evaluation demonstrated various degrees of fibrous
sheath formation, limited immunological infiltration, and no overgrowth of host endothelium.
Conclusions: Bioprosthetic glutaraldehyde-treated mitral valves can be implanted into the mitral position in pigs
and function after 6 months. Echocardiographic data, calcification, and histological examinations were comparable
to results obtained in sheep models and human demonstrating the suitability of the porcine model.
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Introduction
Glutaraldehyde-treated bioprosthetic heart valves are
commonly used for replacement of diseased heart valves.
In the mitral position, glutaraldehyde-treated valves are
preferred in elderly patients (>65 years), in patients in
whom successful repair is unlikely, in rheumatic disease
and endocarditis, and when the use of anticoagulation
therapy is contraindicated [1]. The failure rate of current
bioprosthetic mitral valves is much higher than that of
aortic valves and reoperation is needed in 50% after 15
years [2]. Therefore, the development of new and
improved bioprosthetic valve designs is needed. To
evaluate bioprosthetic heart valves before clinical imple-
mentation, animal testing is preferred. Several species
(sheep, dog, and pig) have been chosen for valve evalua-
tion, the sheep model being the most common [3-6].
The sheep model, however, has several limitations. It
failed to demonstrate the thrombogenecity of the Med-
tronic Parallel mechanical valve, which, after implanta-
tion in patients, was associated with a high incidence of
valve-related thrombosis. It also failed to show a strong
inflammatory response toward a decellularized biological
valve, Synergraft, which was seen after implantation in
children [7,8]. The anatomical and physiological simila-
rities between pigs and humans in terms of heart size,
cardiac output, blood pressure, and, in particular, plate-
let adhesive properties make this model suitable for
heart valve evaluation [9-11].
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any medium, provided the original work is properly cited.To evaluate new bioprosthetic valves, it is essential to
know how these perform in an animal model compared
with standard glutaraldehyde-treated valves, which are
considered the gold standard of bioprosthetic valves.
We, therefore, chose the pig model to thoroughly evalu-
ate standard glutaraldehyde-treated bioprosthetic stented
porcine valves in the mitral position in a long-term
model.
Materials and methods
This observational study was conducted in female Dan-
ish Landrace/Yorkshire pigs. The study material com-
prised eight, 5-month old, 60-kg pigs. All pigs received a
size 27, glutaraldehyde-treated, stented, Carpentier-
Edwards S.A.V. mitral valve prosthesis.
All animal experiments were conducted according to
the guidelines given by the Danish Inspectorate for Ani-
mal Experimentation and after specific approval from
this institution. Qualified animal caretaker personnel
monitored the health status of the animals daily during
the study period. Analgesics were administered if ani-
mals exhibited any sign of pain. In the case of refractory
pain or failure to thrive, the animals were euthanized.
At the end of the study, the animals were euthanized
under anaesthesia.
Mitral valve implantation
The operative technique and anesthetic treatment have
been described elsewhere [5]. In brief, after sedation,
intubation and median sternotomy, a cardiopulmonary
bypass was performed and the heart arrested with cold
crystalloid cardioplegia. A size 27 Carpentier-Edwards
mitral bioprosthesis was then implanted through a left
atriotomy. Next, the atrium was closed and a DC coun-
tershock was given. After approximately 45 minutes of
reperfusion, the animal was weaned from the cardiopul-
monary bypass and the chest closed in a standard man-
ner. The chest drains were removed when satisfactory
hemodynamics were obtained and drain production was
below 50 ml/h. The animals were awakened after 4
hours and transported to the farm in the evening.
Importantly, no antithrombotic therapy was given dur-
ing the follow-up period.
Preexplant analysis
Echocardiography was performed using a commercially
available system (Vivid E9, General Electric, Horten,
Norway) in supine pigs under anesthesia. Parasternal
echocardiograms were obtained by a transthoracic
approach, and apical echocardiograms were obtained
through a minimal abdominal incision. The study pro-
tocol included 2-dimensional echocardiograms with
color Doppler images (apical four chamber, two cham-
ber, long axis, as well as parasternal long axis) to
evaluate left ventricular ejection fraction and mitral
regurgitation using visual assessment by an experienced
observer [12]. To measure blood velocities and pres-
sure differences over the artificial valves, continuous-
wave Doppler echocardiograms through the center of
the mitral ostium were obtained [13]. All echocardio-
grams were recorded twice including three consecutive
heart beats, and analyzed offline using commercial soft-
ware (Echopac, General Electric-Vingmed, Horten,
Norway).
Explantation
The animals were euthanized after 6 months, and the
valves were explanted after administration of an intrave-
nous dose of 10.000 IU unfractionated heparin. Animals
that died during the first postoperative week were
excluded from the study. If the animals exhibited failure
to thrive later than 1 week postoperatively, they were
euthanized and the valve was explanted.
Postexplant analysis
Gross Examination
All valves were inspected in situ and photographed after
removal. Inspection included gross assessment of fenes-
tration, thrombotic material, and vegetations. The
amount of thrombotic material was quantified in terms
of size, appearance, and location.
Radiography
High Resolution X-ray was performed to evaluate loca-
tions and distribution of calcifications using an Xpert
40™, Kubtec technologies, Milford, CT, USA.
Histological evaluation
Cusps and housing site tissues were removed from the
stent and transected radially. Next, the tissue was fixated
in formaldehyde and embedded in paraffin. Hematoxy-
lin-eosin (H&E), vimentin (monoclonal mouse antivi-
mentin), elastin trichrome, von Willebrand factor
(polyclonal rabbit antihuman, DAKO) (endothelial cell),
smooth muscle cell actin (monoclonal mouse antihu-
man, DAKO) (smooth muscle cell), and von Kossa
stains were used to evaluate areas of recellularization,
cell type, structural changes in the trilaminar cusp archi-
tecture, and both intrinsic and extrinsic calcification
foci. Cells with a clear red u c t i o ni nb a s o p h i l i aa n d
increase in eosinophilia in H&E stains as well as a nega-
tive vimentin stain were considered donor cells. Vimen-
tin-positive cells were therefore considered to be host
cells and were afterwards correlated with cell-specific
stains to verify their phenotype in order to differentiate
between host and donor cells. The specimens were eval-
uated as a single observer, nonblinded assessment. The
equipment used for histological assessment and image
capturing was an Olympus BX50 microscope with
Olympus Power View II camera.
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Standard descriptive statistics (means, standard devia-
tions, medians, and ranges) were used to characterize
the investigated valves. Blood velocity was expressed as
median peak and mean velocity. Pressure difference was
expressed as median peak and mean pressure difference.
Results
Eight Carpentier-Edwards S.A.V. mitral valves were
implanted into the mitral position. One pig was eutha-
nized after 5 days because of failure to thrive and
respiratory insufficiency. The valve was found to be
competent without alterations compared with the same
valve at the time of implantation. One pig was eutha-
nized after 3 months because of sudden unexplained
lower limb paralysis. Gross anatomy and histologic eva-
luation of the valve from this pig revealed a well-func-
tioning valve prosthesis with a minor thrombosis in the
commissural area and no endocarditis. One pig died
suddenly after 4 months. Autopsy revealed severe
thrombosis of the valve and histological evaluation
showed infective endocarditis and calcification of all
cusps. Five pigs survived the 6-month follow-up.
Echocardiography
The median peak and mean velocities over the valves were
1.61 m/s (range: 1.17-2.00) and 1.20 (SD = ±0.25), respec-
tively, and the median peak and mean pressure differences
over the valves were 10.42 mmHg (range: 5.83-16.55) and
6.51 mmHg (SD = ±2.57), respectively. All velocities and
pressure differences were within the normal ranges for
Carpentier-Edwards mitral valves implanted into humans
(14). Three animals had mild central mitral regurgitation,
and all animals had normal left ventricular ejection frac-
tions. No paravalvular leaks were observed.
Gross pathology
All valves were without fenestrations or tears. Minor
thrombotic depositions were observed at two commis-
sures in two valves and at all three commissures in
three valves (Figure 1A &1B). In two of these three
valves, the depositions were severe and stretched from
the commissures into the cusps, exhibiting a triradiate
pattern of thrombus deposition on the inflow aspect at
the belly and coaptation areas of the valve (Figure 1C).
Four valves had minor fibrin depositions in the belly
area of one or more of the cusps. Hemorrhages were
seen in one cusp in three valves and two cusps in one
valve. The stent posts and sewing ring were in all cases
covered with a layer of fibrous sheath stretching from
the endocardium toward the cusps.
Radiography
High resolution X-ray imaging revealed the presence of
calcification in variable degrees in all explanted valves
compared with high resolution X-ray imaging of a con-
trol valve that had not been implanted (Figure 2A). In
all valves, calcification was observed in varies degrees in
the stent adjacent area. In three valves, minor calcific
depositions were seen at two of the commissures (Figure
2B-D). In the other two valves, more severe calcification
could be observed at all three commissures, and in both
of these, parts of the belly region of either one or all
three cusps exhibited calcific depositions (Figure 2E-F).
Histological evaluation
H&E stain revealed the presence of nonvital donor cell
remnants throughout the valve tissue. These cells were
characterized by a negative vimentin stain and appeared
less basophilic compared with host cells. Fibrous sheath
formation was observed in all valves to various degrees;
in two valves, the fibrous sheath stretched from both
the atrial and ventricular sides to the base of the cusp.
Between the donor tissue and the fibrous sheath, inflam-
matory cells could be seen in small numbers in all
valves (Figure 3). Fibroblast ingrowth was limited to the
fibrous sheath and as a part of an inflammatory
response in the stent-adjacent area. No cusp ingrowth
of fibroblasts was seen in any of valves. Host cells were
almost absent in the cusp tissue except for in one valve
where infiltration of macrophages and lymphocytes
could be noted. Only a few minor fibrin depositions
Figure 1 Gross anatomy 6 months after implantation. A) Minor thrombotic deposits with calcifications are seen at two of the commissures.
B) Severe thrombocalcific deposits involving the belly area can be observed. C) A triradiate pattern of thrombocalcific deposits on the inflow
aspect of the coaptation area.
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one valve where larger depositions could be seen. Von
Kossa stains revealed severe calcification of the stent
adjacent area, annulus, and myocytes in three valves.
Intrinsic calcification of the cusp was observed in two
valves (Figure 4). Inflammatory cells consisting of
macrophages and lymphocytes were associated with the
calcifications seen in the stent-adjacent areas, but no or
only very few inflammatory cells were seen in the
presence of cusp calcification. Inflammatory cells were
observed in the outer parts of all valves and to a larger
degree if a myocardial muscle shelf was present. The
cusp tissue, collagen, and elastin appeared well pre-
served, with clear demarcations of the different laminae
except for the calcified areas of the cusps (Figure 5).
Intracuspal erythrocytes could be seen in the cusps of
three valves but in limited amounts. Limited tissue frag-
mentation and collagen loosening were only observed in
the basal part of two valves (Figure 6). Von Willebrand
factor-positive cells could only be seen superimposing
Figure 2 High resolution X-ray after the sewing ring and stent have been removed. A) Not implanted control valve without any
calcification. B-D) Minor calcific depositions can be seen at two of the commissures. E-F) Various degrees of calcification involving all three
commissures and parts of the belly area.
Figure 3 Histological imaging of the donor tissue (left) and
host tissue in the stent-adjacent area (right). Non-vital, less
basophilic cell remnants can be clearly seen (arrows). Inflammatory
cell response is seen between the donor tissue and the fibrous
sheath (H&E stain; ×400).
Figure 4 Intrinsic calcification (asterisks) and thrombotic
deposits (arrows) of the valve cusp (H&E stain; ×40)
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factor-positive cells or continuous single-cell layer could
be seen in any of the cusps.
Comment
In this study, we evaluated bioprosthetic glutaraldehyde-
treated valves in the mitral position in juvenile pigs for
valve complications 6 months after implantation. Few
have studied bioprosthetic valves in the mitral position
in pigs, and the present study is the first to thoroughly
evaluate the performance of glutaraldehyde-treated
valves in a long-term porcine model [15-17].
Using high resolution X-ray imaging and von Kossa
stain, we found that calcification was apparent in all
explanted valves. Calcification of the commissures could
be seen in all valves to various degrees and involved the
b e l l ya r e ao ft h ec u s p si nt w ov a l v e s .T h r o m b o t i c
deposits were especially prominent in connection with
the commissural calcifications. Weber et al. found calci-
fication in the aortic area in six of nine Mosaic valves
explanted after 20 weeks in a sheep model, and in no
cases was cusp calcification observed. The Hancock
Standard valve was tested in the same study, and here
calcification was focused in the aortic wall and commis-
sures and occasionally at the base of the cusps [18].
Flaming et al. found that calcification were preferentially
located at the commissures and present in two of six
Perimount valves and four of nine Trilogy valves after
implantation in sheep [6]. Additionally, cusp and wall-
adjacent calcifications were less frequent. These findings
by other groups correspond very well with those of the
present study, and this demonstrates the suitability of
the porcine model for the evaluation of calcification in
bioprosthetic valves.
In a large study in sheep, Flameng et al. found by
means of quantitative calcium content analysis signifi-
cantly lower calcification of the cusps than in the aortic
wall portions of the valve [19]. Furthermore, the highest
calcium levels were found in the commissures, and the
lowest calcium levels were found in the edges of the
cusps. Although we did not perform any quantitative
calcium content analysis, these results correlate well to
the spatial distribution of calcification observed in the
present study by means of high resolution X-ray.
Histological evaluation of the investigated valves
revealed the presence of non-vital donor cell remnants
and very scarce amounts of host cell ingrowth. Fibro-
blasts were only found in the fibrous sheath or as a part
of an inflammatory response toward the outer part of
the stent-adjacent area, and endothelial cells could only
be identified superimposing the fibrous sheath or as von
Willebrand-positive cells in very limited numbers. A
host cell inflammatory response was apparent in all
valves but limited to the stent-adjacent areas except for
one valve in which cusp infiltration was observed. Most
of the explanted valves in this study presented with
well-preserved trilaminar cusp tissue. Inflammatory cells
were infrequently seen in the cusps and mostly limited
to the stent-adjacent areas and muscle shelf tissues. The
tissue preservation of glutaraldehyde-treated valves was
also observed in recent sheep studies in which the cusps
appeared well-preserved and contained wavy collagen
[6,18]. However, Duarte et al. reported trilaminar struc-
ture disruption of the Mosaic valve both with and with-
out alpha amino oleic acid (AOA) treatment [20].
Despite meticulous histological examination, we
observed almost no endothelial cells except for those
located on the surface of fibrous sheaths, and fibroblast
ingrowth was limited to the inflammatory host response
seen in the stent-adjacent areas of most of the valves.
Therefore, recellularization of glutaraldehyde-treated
Figure 5 Histological image of the valve cusp. The tissue
appears well preserved, with corrugations and lack of inflammatory
response (H&E stain; ×100)
Figure 6 In two valves, fragmentation of the lamina spongiosa
is seen, with the absence of corrugations (Weigers stain; ×100)
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period of 6 months, which corresponds well with human
studies of bioprosthetic valve endothealization [21].
We found that both blood velocities and pressure dif-
ferences across the valve after 6 months were compar-
able with human studies of the Carpentier-Edwards S.A.
V. valve in the mitral position as well as previous sheep
studies by Duarte et al. and Irwin et al. [20,22]. Flaming
et al. found peak velocites (m/s) of 1.34 (0.89, 1.47) and
1.11 (0.75, 1.54) and mean gradients (mmHg) of 3.6
(3.0, 5.2) and 2.4 (1.7, 5.4) for the Perimount and Tril-
ogy valves, respectively, after 5 months in a sheep
model. Although a higher mean pressure difference was
found in the present study, most likely caused by the
thrombotic deposits in some of the valves, we consider
our results to be comparable. Additionally, we observed
trivial regurgitation in three valves, a finding which was
also noted by Weber et al. in another study [14]. In our
study, the thrombotic depositions could have caused
some degree of commissural fusion leading to a limita-
tion in cusp movement and minimal valve insufficiency.
Our aim was to evaluate the porcine model for long-
term testing of bioprosthetic mitral heart valves. The por-
cine mitral valve anatomy has already been verified to be
very similar to human mitral valve anatomy [23,24]. The
present study demonstrates that the porcine model is a
reliable animal model for long-term bioprosthetic heart
valve evaluation and can be used in the future as a rele-
vant, important, and demanding animal model. The find-
ings in the present study speak for the pig as being an
animal model for heart valve evaluation that can provide
a satisfactory answer to the question of animal testing
that will avoid later tragic clinical incidents such as those
seen after preclinical sheep experiments. Thorough eva-
luation of heart valve bioprostheses is critical before any
clinical use. Therefore, we consider the present animal
model to be very suitable for preclinical bioprosthetic
mitral valve testing to ensure proper patient care. Further
validation of the porcine model from other groups to
support our findings should be performed to verify the
pig as a clinically valid animal model. Especially interest-
ing would be the evaluation of other tissue valves, decel-
lularized valves, and tissue-engineered polymer valves
because of the recent focus on this topic.
Study Limitations
A small number of animals were included in this study.
However, because of the comparable results between the
animals, we consider the number to be sufficient for the
evaluation of the porcine model as a tool for biopros-
thetic mitral valve evaluation. No anticoagulation ther-
apy was used during the follow-up period, and this
could have resulted in the thrombotic deposits observed.
A more aggressive anticoagulation strategy might have
limited this problem. No baseline echocardiography was
performed postoperatively, and hemodynamic compari-
son with pre-explantation echocardiography was there-
fore not possible. The growth potential of the pig could
result in a patient-prosthesis mismatch, however, we do
not consider this a limiting factor, since all surviving
pigs thrived well at euthanization, and none of the three
animal deaths before the six months follow-up could be
related to mitral stenosis.
Conclusion
Bioprosthetic glutaraldehyde-treated mitral valves can be
implanted into the mitral position in pigs and function
after a period of 6 months. Echocardiographic data, cal-
cification, and histological examinations were compar-
able to results obtained in sheep and humans, and we
therefore consider the porcine model an appropriate
animal model for bioprosthetic mitral valve testing.
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